Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2013-06-26FDA Approved: DOCETAXEL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for docetaxel, resulting in changes to the product labeling. The changes may include updates to indi…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating amifostine to reduce treatment-related side effects in patients receiving radiation therapy and cisplatin for advan…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Radiation Therapy in Treating Patients With Head and Neck Cancer [Phase 3]
Phase 3 clinical trial evaluating radiation therapy for head and neck cancer has completed (status: COMPLETED). The study also lists non-mel…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study evaluating combination chemotherapy plus radiation therapy in patients …
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors [Phase 1]
A Phase 1 study of L-778,123 in patients with recurrent or refractory solid tumors, including head and neck cancer, has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial evaluating Bryostatin 1 in patients with metastatic or recurrent head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients [NA]
This is a completed clinical trial evaluating the efficacy of a novel edible gel-based artificial saliva for managing dry mouth in cancer pa…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer [Phase 1]
Phase 1 clinical trial update evaluating chemotherapy in patients with refractory advanced solid tumors or hematologic cancers across multip…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer [Phase 3]
This document reports an update on a Phase 3 trial evaluating combination chemotherapy in patients with advanced head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors [Phase 2]
Phase 2 trial evaluating a combination of vaccine therapy and a biological therapy in adults with metastatic solid tumors; the study include…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors [Phase 1, Phase 2]
This clinical trial update covers the pediatric use of temozolomide in combination with peripheral stem cell transplantation for newly diagn…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer [Phase 2]
A Phase 2 study evaluating the combination of cetuximab, cisplatin, and radiation therapy for advanced stage III/IV head and neck cancer has…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating flavopiridol in patients with recurrent or metastatic head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy [Phase 1, Phase 2]
A clinical trial evaluating swallow-exercise therapy as prophylaxis against radiation-induced dysphagia in head and neck cancer patients has…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating palliative radiotherapy for head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating the combination of BMS-754807 with Erbitux (cetuximab) in advanced or metastatic colorectal cancer a…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Effect of Nutri-jelly on Quality of Life in Head and Neck Cancer Patients [NA]
A completed clinical trial evaluated Nutri-jelly on quality of life in head and neck cancer patients. The trial also included participants w…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating perifosine for recurrent or metastatic head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating interleukin-2 gene therapy or methotrexate in patients with recurrent or refractory stage III/IV head and neck canc…
-
CLINICAL_TRIALS trial_result · 2013-05-24Clinical Trial Update: A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy [EARLY_Phase 1]
A feasibility study in early Phase 1 evaluating adaptive intensity-modulated radiation therapy for head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Normalcy of Food Intake in Head and Neck Cancer Patients [NA]
This clinical trial update reports the completed status of a study investigating normal food intake in patients with head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer [NA]
This clinical trial update concerns using L-lysine to treat oral mucositis in patients receiving radiation therapy with or without chemother…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer [Phase 3]
Phase 3 trial evaluating GM-CSF mouthwash to prevent and treat mucositis in patients undergoing radiation therapy for head and neck cancer; …
-
CLINICAL_TRIALS research · 2013-05-15Clinical Trial Update: S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer [Phase 3]
This is a Phase 3 clinical trial evaluating S-1 or Tegafur-Uracil in patients with previously treated stage III or stage IV head and neck ca…
-
CLINICAL_TRIALS research · 2013-05-15Clinical Trial Update: Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking [NA]
This clinical trial update reports a completed study on computer-assisted scheduling of nicotine inhaler use in participants planning to qui…